Sky Labs Inc. (386380.KQ) stock: key figures, P/E, revenue and dividend

Health Care · South Korea

Price
9,620.00 KRW
Market cap
180.49 bn KRW
P/E (2025)
–
P/S (2025)
22.74
Dividend yield
0.00 %
Net margin
-793.80 %
Return on equity (ROE)
-247.50 %
Return on assets (ROA)
-208.72 %

Sky Labs Inc. financials

Fiscal year20242025
Revenue4.09 bn KRW7.94 bn KRW
Gross profit-1.07 bn KRW3.91 bn KRW
Operating income-11.73 bn KRW-14.73 bn KRW
EBIT-8.15 bn KRW-56.78 bn KRW
Net income-12.67 bn KRW-63.00 bn KRW
Diluted EPS – continuing operations-675.17 KRW-3,357.60 KRW

Full history since 2022, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

About Sky Labs Inc.

Sky Labs Inc. manufactures CART BP pro, a ring-type medical device as a blood pressure monitoring solution for healthcare professionals and patients. The company provides health monitoring services to prevent chronic disease as an AI healthcare platform company. Additionally, it develops CART ON, a healthcare platform that collects, analyzes, diagnoses, and distributes data from outpatients with chronic diseases. The company's device CART BP pro helps with accurate diagnosis and individualized medication by offering 24-hour ambulatory blood pressure monitoring data and health evaluation metrics. Sky Labs Inc. was founded in 2015 and is based in Seongnam-si, South Korea.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 30.10.2026. Details in the risk notice.